Supreme Court Ruling Closes Courthouse Doors for Roundup Victims

For over a decade, more than 200,000 Americans have pursued litigation against Monsanto, now owned by Bayer, alleging that the glyphosate-based herbicide Roundup caused their non-Hodgkin's lymphoma. These legal battles have forced the company to commit roughly $10 billion in settlements to resolve nearly 100,000 claims. However, the recent Supreme Court ruling effectively narrows the legal pathway for future plaintiffs by shielding manufacturers from state-based claims that they failed to adequately warn users of potential cancer risks.

The ruling relies on Environmental Protection Agency classifications that have long faced scrutiny. While the Court cited the agency’s assessment that glyphosate is not likely carcinogenic, a 2022 federal court decision previously struck down that very determination, finding that the EPA violated its own scientific standards. Critics argue the EPA has failed to properly label roughly 200 pesticide ingredients identified as potential carcinogens, leaving the public exposed to products that exceed safety benchmarks. With one legal avenue restricted, the focus now shifts toward congressional action and the work of watchdog organizations like the Center for Food Safety, which continue to challenge pesticide approvals in court. Despite the industry victory, the underlying reality remains: millions of pounds of glyphosate are sprayed annually across American farmland, leaving the chemical detectable in food, water, and human bodies.